The research & development by business enterprise, pharmaceutical industry in constant ppp $ in China is now 21,406.92 million, marking a 2,773.95 million (14.9%) increase compared to 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in China
No matching regions
Similar regions to China
Business R&D pharmaceutical in constant PPP $
China Business R&D pharmaceutical in constant PPP $ between 2000 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 21,406.92M | +2,773.95M |
| 2020 | 18,632.98M | +4,063.64M |
| 2019 | 14,569.33M | +527.88M |
| 2018 | 14,041.46M | +677.17M |
| 2017 | 13,364.29M | +626.22M |
| 2016 | 12,738.07M | +1,063.98M |
| 2015 | 11,674.09M | +1,352.71M |
| 2014 | 10,321.38M | +1,033.32M |
| 2013 | 9,288.06M | +1,555.45M |
| 2012 | 7,732.62M | +1,832.39M |
| 2011 | 5,900.23M | +871.82M |
| 2010 | 5,028.40M | +687.74M |
| 2009 | 4,340.67M | +1,029.37M |
| 2008 | 3,311.29M | +2,244.11M |
| 2000 | 1,067.18M |